Table: begin end state 1 13 cytoplasmic 14 36 transmembrane 37 47 non-cytoplasmic 48 66 transmembrane 67 95 cytoplasmic 96 114 transmembrane 115 119 non-cytoplasmic 120 142 transmembrane 143 147 cytoplasmic 148 167 transmembrane 168 172 non-cytoplasmic 173 193 transmembrane 194 199 cytoplasmic 200 220 transmembrane 221 263 non-cytoplasmic 264 283 transmembrane 284 314 cytoplasmic 315 338 transmembrane 339 352 non-cytoplasmic 353 378 transmembrane 379 389 cytoplasmic 390 407 transmembrane 408 426 non-cytoplasmic
Input: >Pf6N2E2_3578 MSAANKPLDIKQSVIDAILAGLISLIVFGPIVGVVLDGYSFNLQPARVGWLVAIVMIGRF ALSLFLQTPKGLKILQGFESTGSGVHVLPPDYKSRLRWIIPALIVIAIVFPFFANKYVLT VVILGLIYVLLGLGLNIVVGLAGLLDLGYVAFYAIGAYGLALGYQYLGLGFWTVLPLAAI AAAMAGCILGFPVLRMHGDYLAIVTLGFGEIIRLVLNNWLSFTGGPNGMPVPSPTFLGLE FGRRAKDGGVPFHEFFGIDYNPNIKFLFIYIVLFITVLLVLYVKHRLTRMPVGRAWEALR EDEIACRSMGLNHVLVKLSAFTIGASTAGLAGVFFASYQGFVNPSSFTFFESALILAIVV LGGMGSTVGVVIAAFVLTVAPELLRSFSEYRVLLFGVLMVLMMIWRPRGLIRISRTGVTP RKGVAP
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server